Among patients receiving semaglutide for obesity management, the risk for muscle loss may be higher in older adults and women ...

Semaglutide, a popular anti-obesity drug, may come with a hidden cost: significant muscle loss, especially in women and older ...

In a real-world setting, the administration of oral semaglutide leads to a significant reduction in the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and albuminuria.

If you’ve been taking Ozempic or Wegovy (both of which contain the active ingredient semaglutide), you might wonder, How long ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type ...

Most policies still exclude weight-loss medications under general exclusions unless they are part of the treatment of a ...

Case Western Reserve researchers found semaglutide users had significantly lower Alzheimer's-related dementia risk compared ...

The market for generic GLP-1 weight loss drugs in Canada is set to open up, and Hims & Hers is ready to jump in.  | Novo ...

The partnership between the Danish pharmaceutical giant and the splashy telehealth firm Hims & Hers was strained from the ...

Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.

New research published Tuesday concludes that the rising rate of extreme childhood obesity—well above the usual BMI ...